Tonghua Dongbao Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Tonghua Dongbao Pharmaceutical Co Ltd cash flow-to-debt ratio. Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of CN¥62.99 Million could theoretically repay 0% of its total liabilities (CN¥1.02 Billion) in one year. Check 600867 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Tonghua Dongbao Pharmaceutical Co Ltd (1998–2025)
Cash flow-to-debt ratio of Tonghua Dongbao Pharmaceutical Co Ltd from 1998 to 2025. Historical debt coverage capacity for Tonghua Dongbao Pharmaceutical Co Ltd across 28 annual periods. Check Tonghua Dongbao Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Tonghua Dongbao Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (1998–2025)
Tonghua Dongbao Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for Tonghua Dongbao Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Tonghua Dongbao Pharmaceutical Co Ltd cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.86x | CN¥689.23 Million | CN¥798.84 Million | ▲ +83.6% |
| 2024 | 0.47x | CN¥459.74 Million | CN¥978.08 Million | ▼ -69.7% |
| 2023 | 1.55x | CN¥861.52 Million | CN¥555.08 Million | ▼ -63.9% |
| 2022 | 4.30x | CN¥863.09 Million | CN¥200.74 Million | ▲ +13.6% |
| 2021 | 3.78x | CN¥1.13 Billion | CN¥299.87 Million | ▼ -22.6% |
| 2020 | 4.89x | CN¥1.19 Billion | CN¥243.80 Million | ▲ +44.8% |
| 2019 | 3.38x | CN¥1.15 Billion | CN¥341.10 Million | ▲ +180.8% |
| 2018 | 1.20x | CN¥876.94 Million | CN¥729.06 Million | ▼ -73.1% |
| 2017 | 4.46x | CN¥961.19 Million | CN¥215.30 Million | ▲ +348.9% |
| 2016 | 0.99x | CN¥725.76 Million | CN¥729.76 Million | ▲ +342.0% |
| 2015 | 0.23x | CN¥294.58 Million | CN¥1.31 Billion | ▼ -13.0% |
| 2014 | 0.26x | CN¥205.89 Million | CN¥795.72 Million | ▼ -20.6% |
| 2013 | 0.33x | CN¥221.06 Million | CN¥678.23 Million | ▼ -34.8% |
| 2012 | 0.50x | CN¥194.32 Million | CN¥388.92 Million | ▲ +371.6% |
| 2011 | -0.18x | CN¥-55.07 Million | CN¥299.37 Million | ▼ -152.0% |
| 2010 | 0.35x | CN¥160.40 Million | CN¥453.75 Million | ▲ +32.9% |
| 2009 | 0.27x | CN¥166.20 Million | CN¥624.75 Million | ▲ +112.6% |
| 2008 | 0.13x | CN¥92.31 Million | CN¥737.66 Million | ▼ -23.9% |
| 2007 | 0.16x | CN¥120.94 Million | CN¥734.97 Million | ▼ -28.0% |
| 2006 | 0.23x | CN¥158.00 Million | CN¥691.13 Million | ▲ +34.9% |
| 2005 | 0.17x | CN¥92.23 Million | CN¥544.23 Million | ▲ +518.0% |
| 2004 | 0.03x | CN¥13.17 Million | CN¥480.12 Million | ▼ -76.3% |
| 2003 | 0.12x | CN¥45.51 Million | CN¥393.95 Million | ▼ -25.8% |
| 2002 | 0.16x | CN¥31.99 Million | CN¥205.52 Million | ▼ -89.7% |
| 2001 | 1.51x | CN¥117.73 Million | CN¥77.96 Million | ▲ +128.7% |
| 2000 | 0.66x | CN¥29.12 Million | CN¥44.10 Million | ▲ +164.4% |
| 1999 | -1.02x | CN¥-95.09 Million | CN¥92.79 Million | ▼ -18.0% |
| 1998 | -0.87x | CN¥-216.98 Million | CN¥249.82 Million | — |